Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid. - Keitel WA; Kester KE; Atmar RL; White AC; Bond NH; Holland CA; Krzych U; Palmer DR; Egan A; Diggs C; Ballou WR; Hall BF; et al. (Vaccine, 1999)